Telomere length measurement can distinguish pathogenic from non‐pathogenic variants in the shelterin component, TIN2
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Vulliamy T, Beswick R, Kirwan MJ, Hossain U, Walne AJ, Dokal I. Telomere length measurement can distinguish pathogenic from non‐pathogenic variants in the shelterin component, TIN2. Dyskeratosis congenita (DC) is a heterogeneous bone marrow failure syndrome with seven disease‐causing genes identified to date, six of which are linked to telomere maintenance. Mutations in one of these genes (TINF2), which encodes a component of the shelterin complex, are associated with particularly short telomeres. Among the 224 consecutive patients with different forms of bone marrow failure (46 with DC, 122 with aplastic anaemia and 57 with some features of DC), we have identified 16 new families with variants in exon 6 of the TINF2 gene, eight of which are novel. We observe that the phenotype associated with these mutations extends to a severe early presentation, not always classified as DC. In addition, we see that some of the variants identified are not associated with short telomeres and are also found in asymptomatic individuals. In the absence of any direct functional assay, the data indicates that the telomere length measurement can inform us as to which variants in TINF2 are pathogenic and which may be non‐pathogenic.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960 · cited 1×
“Telomere lengths were measured by Southern blot analysis using a subtelomeric probe from the short arm of chromosome 7 as previously described (13).”
MethodSelf-citationRichards, C. S., Bale, S., Bellissimo, D. B., Das, S., Grody, W. W., Hegde, M. R., Lyon, E., & Ward, B. E. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e31816b5cae · Cited by 832
Dyskeratosis congenita in all its forms
Dokal, I. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02109.x · Cited by 575
Self-citationTIN2, a new regulator of telomere length in human cells
Kim, S.-H., Kaminker, P., & Campisi, J. (1999) · Nature Genetics · doi:10.1038/70508 · Cited by 525 · cited 1×
“This protein is called TIN2, the telomeric repeat binding factor 1 (TRF1)-interacting nuclear factor 2; it is an essential mediator of TRF1 function and acts as an important regulator of telomere length (6, 7).”
BackgroundSavage, S. A., Giri, N., Baerlocher, G. M., Orr, N., Lansdorp, P. M., & Alter, B. P. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.10.004 · Cited by 414 · cited 6×
“Both of the mutations to the Arg282 residue have been reported previously as disease causing and are seen to occur repetitively among patients who have a relatively severe form of the disease (4, 5, 14).”
BackgroundInfluentialWalne, A. J., Vulliamy, T., Beswick, R., Kirwan, M., & Dokal, I. (2008) · Blood · doi:10.1182/blood-2008-05-153445 · Cited by 317 · cited 10×
“Both of the mutations to the Arg282 residue have been reported previously as disease causing and are seen to occur repetitively among patients who have a relatively severe form of the disease (4, 5, 14).”
BackgroundResultInfluentialSelf-citationDu, H.-Y., Pumbo, E., Ivanovich, J., An, P., Maziarz, R. T., Reiss, U. M., Chirnomas, D., Shimamura, A., Vlachos, A., Lipton, J. M., et al. (2009) · Blood · doi:10.1182/blood-2008-07-166421 · Cited by 158
Cited by
Shaping human telomeres: from shelterin and CST complexes to telomeric chromatin organization
Lim, C. J., & Cech, T. R. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00328-y · Cited by 273
Telomere length is associated with disease severity and declines with age in dyskeratosis congenita
Alter, B. P., Rosenberg, P. S., Giri, N., Baerlocher, G. M., Lansdorp, P. M., & Savage, S. A. (2012) · Haematologica · doi:10.3324/haematol.2011.055269 · Cited by 238
Telomeropathies: An emerging spectrum disorder
Holohan, B., Wright, W. E., & Shay, J. W. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201401012 · Cited by 175
Beier, F., Foronda, M., Martinez, P., & Blasco, M. A. (2012) · Blood · doi:10.1182/blood-2012-03-418038 · Cited by 79
Hematopoietic stem cells are acutely sensitive to Acd shelterin gene inactivation
Jones, M., Osawa, G., Regal, J. A., Weinberg, D. N., Taggart, J., Kocak, H., Friedman, A., Ferguson, D. O., Keegan, C. E., & Maillard, I. (2014) · Journal of Clinical Investigation · doi:10.1172/jci67871 · Cited by 18
“Numbers indicate the percentage of cells in each gate. mutations in aplastic anemia and TINF2 mutations in a severe form of DKC that exhibited exceptionally short telomeres and early onset (24–29).”
Background
Metadata
- Authors
- Vulliamy, T., Beswick, R., Kirwan, M., Hossain, U., Walne, A., & Dokal, I.
- Venue
- Clinical Genetics
- Publisher
- Wiley
- Published
- 2011-01-04
- Volume
- 81
- Issue
- 1
- Pages
- 76-81
- ISSN
- 0009-9163 (ISSN-L)
- 1399-0004
- OpenAlex
- W2029860584
- Cited by
- 39
- References
- 7
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Telomere length measurement can distinguish pathogenic from non‐pathogenic variants in the shelterin component, TIN2. https://app.cochat.ai/papers/10.1111/j.1399-0004.2010.01605.x
- The paper
- Vulliamy, T., Beswick, R., Kirwan, M., Hossain, U., Walne, A., & Dokal, I. (2012). Telomere length measurement can distinguish pathogenic from non‐pathogenic variants in the shelterin component, TIN2. Clinical Genetics. https://doi.org/10.1111/j.1399-0004.2010.01605.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.